Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Günter Schneider

Showing results (1-10 of 144) with videos related to

Pageof 15
Sort By:
Trends in Cancer|July 26, 2017
In Vivo RNAi Screening for Pancreatic Cancer Drivers: PILOTing the WDR5-MYC AxisGünter Schneider, Dieter Saur
Cancer Research|June 4, 2024
A Hypoxia-Epigenetics Axis Drives EMT in Pancreatic CancerMatthias Wirth, Günter Schneider
Trends in Cancer|July 26, 2017
MYC: A Stratification Marker for Pancreatic Cancer TherapyMatthias Wirth, Günter Schneider
Gastroenterology|June 5, 2021
New Insights Into Pancreatic Cancer: Notes from a Virtual MeetingElisabeth Hessmann, Günter Schneider,
Clinical and Translational Medicine|May 23, 2022
Single-cell profiling guided combination therapy of c-Fos and histone deacetylase inhibitors in diffuse large B-cell lymphomaOliver H Krämer, Günter Schneider
Biochimica Et Biophysica Acta|October 19, 2010
NFκB/p53 crosstalk-a promising new therapeutic targetGünter Schneider, Oliver H Krämer
The EMBO Journal|April 3, 2020
Blocking the road to de-differentiation: HNF1A/KDM6A complex safeguards epithelial integrity in pancreatic cancerStefanie Bärthel, Günter Schneider, Dieter Saur
Cancer Discovery|January 11, 2020
Personalizing <i>KRAS</i>-Mutant Allele-Specific TherapiesChiara Falcomatà, Günter Schneider, Dieter Saur
European Radiology|February 27, 2004
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applicationsPeter Reimer, Günter Schneider, Wolfgang Schima
Expert Opinion on Investigational Drugs|October 17, 2006
Pancreatic cancer: a review of recent advancesFlorian Eckel, Günter Schneider, Roland M Schmid
Pageof 15

Showing results (1-10 of 144) with videos related to

Sort By:
Pageof 15
Trends in Cancer|July 26, 2017
In Vivo RNAi Screening for Pancreatic Cancer Drivers: PILOTing the WDR5-MYC AxisGünter Schneider, Dieter Saur
Cancer Research|June 4, 2024
A Hypoxia-Epigenetics Axis Drives EMT in Pancreatic CancerMatthias Wirth, Günter Schneider
Trends in Cancer|July 26, 2017
MYC: A Stratification Marker for Pancreatic Cancer TherapyMatthias Wirth, Günter Schneider
Gastroenterology|June 5, 2021
New Insights Into Pancreatic Cancer: Notes from a Virtual MeetingElisabeth Hessmann, Günter Schneider,
Clinical and Translational Medicine|May 23, 2022
Single-cell profiling guided combination therapy of c-Fos and histone deacetylase inhibitors in diffuse large B-cell lymphomaOliver H Krämer, Günter Schneider
Biochimica Et Biophysica Acta|October 19, 2010
NFκB/p53 crosstalk-a promising new therapeutic targetGünter Schneider, Oliver H Krämer
The EMBO Journal|April 3, 2020
Blocking the road to de-differentiation: HNF1A/KDM6A complex safeguards epithelial integrity in pancreatic cancerStefanie Bärthel, Günter Schneider, Dieter Saur
Cancer Discovery|January 11, 2020
Personalizing <i>KRAS</i>-Mutant Allele-Specific TherapiesChiara Falcomatà, Günter Schneider, Dieter Saur
European Radiology|February 27, 2004
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applicationsPeter Reimer, Günter Schneider, Wolfgang Schima
Expert Opinion on Investigational Drugs|October 17, 2006
Pancreatic cancer: a review of recent advancesFlorian Eckel, Günter Schneider, Roland M Schmid
Pageof 15